Abstract: Provided are a polyamideimide film, a window cover film, and a display panel including the same. More specifically, a polyamideimide film including an amideimide structure derived from a dianhydride, a diamine, and an aromatic diacid dichloride is provided, wherein a chlorine content in the film is 5 to 33 ppm and a yellow index change amount ?YI is 5 or less, the yellow index change amount being measured in accordance with ASTM E313 after repeating a process of irradiating 0.55 W/m2 of UVA at 340 nm at 40° C. for 20 hours and then blocking UVA for 4 hours three times.

Abstract: Provided are a separator coating composition for a secondary battery including inorganic particles and a silane salt compound having a specific structure, a separator using the same, and an electrochemical device including the same. Specifically, a separator coating composition for a secondary battery which implements adhesion between an inorganic material layer and a porous substrate without including an acid/polymer-based organic binder in a coating composition for forming the inorganic material layer on one or both surfaces of the porous substrate and does not need a separate dispersing agent for dispersing the inorganic particles, a separator manufactured using the same, and an electrochemical device including the separator are provided.

Abstract: The present invention relates to a steel sheet used for a line pipe or the like, and particularly, to a steel sheet having excellent hydrogen induced cracking resistance, and longitudinal strength uniformity, and a method for manufacturing the same.

Abstract: Steel sheets and methods for manufacturing same useful for a line pipe or the like can have excellent hydrogen induced cracking resistance, and longitudinal strength uniformity. The Sttel sheets can include certain amounts of carbon (C), silicon (Si), manganese (Mn), phosphorus (P), sulfur (S), aluminum (Al), nitrogen (N), niobium (Nb), titanium (Ti), calcium (Ca), one or more selected from a group consisting of nickel (Ni), chromium (Cr), molybdenum (Mo), vanadium (V), and a balance of iron (Fe) and other inevitable impurities. A microstructure of the steel sheet can be comprised of ferrite or a composite structure of ferrite and acicular ferrite, and upper bainite is included in an area of 5% or less in a center portion of the thickness of the steel sheet.

Abstract: The present invention relates to a thick steel suitable for use as a line pipe, a sour-resistant material, or the like and, more specifically, to a high-strength steel having excellent resistance to sulfide stress cracking, and a method for manufacturing same.

Abstract: The present invention relates to a steel sheet used for a line pipe or the like, and particularly, to a steel sheet having excellent hydrogen induced cracking resistance, and longitudinal strength uniformity, and a method for manufacturing the same.

Abstract: The present invention relates to a compound having a blocking effect against sodium ion channels, particularly Nav1.7, a preparation method thereof and use thereof. The compound represented by the Formula 1 or a pharmaceutically acceptable salt, hydrate, solvate or isomer thereof can be effectively used in the prevention or treatment of pains, for example, acute pain, chronic pain, pain from nervous disease, postoperative pain, migraine, arthralgia, neuropathy, nerve injury, diabetic neuropathy, neuropathic disease, epilepsy, arrhythmia, myotonia, ataxia, multiple sclerosis, irritable bowel syndrome, urinary incontinence, visceral pain, depression, erythromelalgia, paroxysmal extreme pain disorder (PEPD).

Abstract: The invention relates to a compound represented by Chemical Formula 1, below, a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the compound or salt. The compound of the invention or pharmaceutically acceptable salts thereof can be used for the prevention or treatment of sodium channel blocker-related diseases.

Abstract: The present invention relates to a compound represented by Chemical Formula, or a pharmaceutically acceptable salt thereof. The compound according to the present invention can be usefully used for the prevention or treatment of sodium channel blocker-related diseases.

Abstract: The present invention relates to a compound having a blocking effect against sodium ion channels, particularly Nav1.7, a preparation method thereof and use thereof. The compound represented by the Formula 1 or a pharmaceutically acceptable salt, hydrate, solvate or isomer thereof can be effectively used in the prevention or treatment of pains, for example, acute pain, chronic pain, pain from nervous disease, postoperative pain, migraine, arthralgia, neuropathy, nerve injury, diabetic neuropathy, neuropathic disease, epilepsy, arrhythmia, myotonia, ataxia, multiple sclerosis, irritable bowel syndrome, urinary incontinence, visceral pain, depression, erythromelalgia, paroxysmal extreme pain disorder (PEPD).

Abstract: An organic light emitting display device includes a first substrate having a plurality of organic light emitting structures thereon, a second substrate facing the first substrate to encapsulate the organic light emitting structures, an aperture under a lower surface of the first substrate, and an aperture controller under the lower surface of the first substrate. The organic light emitting structures define a pixel area. The second substrate has a light absorption area. The aperture corresponds to the light absorption area. The aperture controller is adjacent to the aperture.

Abstract: An organic light emitting display device includes a first substrate having a plurality of organic light emitting structures thereon, a second substrate facing the first substrate to encapsulate the organic light emitting structures, an aperture under a lower surface of the first substrate, and an aperture controller under the lower surface of the first substrate. The organic light emitting structures define a pixel area. The second substrate has a light absorption area. The aperture corresponds to the light absorption area. The aperture controller is adjacent to the aperture.

Abstract: An organic light emitting display device includes a first substrate having a plurality of organic light emitting structures thereon, a second substrate facing the first substrate to encapsulate the organic light emitting structures, an aperture under a lower surface of the first substrate, and an aperture controller under the lower surface of the first substrate. The organic light emitting structures define a pixel area. The second substrate has a light absorption area. The aperture corresponds to the light absorption area. The aperture controller is adjacent to the aperture.

Abstract: The present invention relates to a compound having a blocking effect against sodium ion channels, particularly Nav1.7, a preparation method thereof and the use thereof. A compound represented by formula 1 according to the invention, or a pharmaceutically acceptable salt, hydrate, solvate or isomer thereof may be effectively used for the prevention or treatment of pain, for example, acute pain, chronic pain, neuropathic pain, post-surgery pain, migraine, arthralgia, neuropathy, nerve injury, diabetic neuropathy, neuropathic disease, epilepsy, arrhythmia, myotonia, ataxia, multiple sclerosis, irritable bowel syndrome, urinary incontinence, visceral pain, depression, erythromelalgia, or paroxysmal extreme pain disorder (PEPD).

Abstract: A proximity of a second user is sensed while a first user who is a registered user views an iris recognition portable device. Whether the second user is registered is checked according to whether an iris of the second user is recognized. The displayed screen may be altered when the second user is determined to be a non-registered user.

Abstract: Provided is a method for preventing or treating a periodontal disease; or a method for improving oral hygiene, including administering a pharmaceutical composition containing tauroursodeoxycholic acid as an active ingredient.

Abstract: The present invention relates to a compound having a blocking effect against sodium ion channels, particularly Nav1.7, a preparation method thereof and the use thereof. A compound represented by formula 1 according to the invention, or a pharmaceutically acceptable salt, hydrate, solvate or isomer thereof may be effectively used for the prevention or treatment of pain, for example, acute pain, chronic pain, neuropathic pain, post-surgery pain, migraine, arthralgia, neuropathy, nerve injury, diabetic neuropathy, neuropathic disease, epilepsy, arrhythmia, myotonia, ataxia, multiple sclerosis, irritable bowel syndrome, urinary incontinence, visceral pain, depression, erythromelalgia, or paroxysmal extreme pain disorder (PEPD).

Abstract: A proximity of a second user is sensed while a first user who is a registered user views an iris recognition portable device. Whether the second user is registered is checked according to whether an iris of the second user is recognized. The displayed screen may be altered when the second user is determined to be a non-registered user.

Abstract: Provided is a method for preventing or treating a periodontal disease; or a method for improving oral hygiene, including administering a pharmaceutical composition containing tauroursodeoxycholic acid as an active ingredient.

Abstract: An organic light emitting display device includes a first substrate having a plurality of organic light emitting structures thereon, a second substrate facing the first substrate to encapsulate the organic light emitting structures, an aperture under a lower surface of the first substrate, and an aperture controller under the lower surface of the first substrate. The organic light emitting structures define a pixel area. The second substrate has a light absorption area. The aperture corresponds to the light absorption area. The aperture controller is adjacent to the aperture.